• On: September 23, 2015 at 09:09AM
    • Category: Conferences


    Q1 Productions

    Global UDI Intensive Workshop


    Location: San Diego, CA

    Throughout the medical device and diagnostic industries, organizations are currently looking to optimize and leverage investments made in the processes and technologies required to support compliant UDI practices. As many organizations have achieved compliance with FDA UDI standards, executives are now looking towards investments in order to identify areas where data can be leveraged to provide further value across the organization. Many executives are now looking towards international UDI regulations with an aim of streamlining processes and procedures on a global level in order to maintain robust compliance with evolving standards.


  • Sunshine Act--How to Avoid Sunburn this Summer!

    • On: June 17, 2015 at 11:06AM
    • Category: Conferences

    DuVal EDU Regulatory Training presents a 90-minute webinar on the Sunshine Act--How to Avoid Sunburn this Summer!



    Later this year medical device, drug and biologics executives will be required to attest to the accuracy of their respective sunshine data before submitting it to CMS. Questions that these executives should be thinking about before attesting to the accuracy and completeness of the data submitted include:

    • Are my data sets correct?

    • Are my data sets in violation of applicable laws or our own internal policies?

    • Are we monitoring compliance and violations?

    • How will our customers react if we submit wrong information?

  • Unbroken: The Story - How to Create a Compliance Program that Survives the Uncertainty of the Government

    • Presented by: Mark DuVal
    • On: May 12, 2015 at 09:05AM
    • Category: Seminars
    Unbroken: The Story - How to Create a Compliance Program that Survives the Uncertainty of the Government.
  • Mobile Medical Apps Webinar

    • On: February 17, 2015 at 11:02AM
    • Category: Conferences

    How does FDA regulate mobile medical applications? What should companies consider when designing and promoting mobile medical apps?  This program will discuss FDA’s Mobile Medical Applications final guidance.  Topics include the FDA’s regulatory oversight of mobile medical apps, e.g., software used on smart phones, tablets and other devices.  This session will discuss the latest updates from FDA relating to mobile Medical apps.

The information on our site is not intended to provide specific legal advice.
Helping clients be appropriately aggressive, yet compliant. TM